Lorazepam Challenge for Individuals at Varying Genetic Risk for Alzheimer Disease

Cynthia M. Stonnington,Brian T. Harel,Dona E.C. Locke,Joseph G. Hentz,Nan Zhang,Paul Maruff,Richard John Caselli

Lorazepam Challenge for Individuals at Varying Genetic Risk for Alzheimer Disease

2017

Cynthia M. Stonnington
Brian T. Harel
Dona E.C. Locke
Joseph G. Hentz
Nan Zhang
Paul Maruff
Richard John Caselli

Introduction:This study set out to clarify the differential acute cognitive impact of lorazepam based on varying genetic risk for Alzheimer disease.Methods:Fifty-seven cognitively unimpaired individuals aged 51 to 88, genotyped according to apolipoprotein E (APOE) and translocase of outer mitochondr

Keywords:

Translocase
Psychology
Psychiatry
Apolipoprotein E
Lorazepam
Cognition
Alzheimer's disease
Diabetes mellitus
Psychomotor learning
Working memory
Verbal memory
Spatial memory
Cognitive test

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations